Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes - PubMed (original) (raw)
. 1999 Mar 11;18(10):1903-10.
doi: 10.1038/sj.onc.1202739.
Affiliations
- PMID: 10086345
- DOI: 10.1038/sj.onc.1202739
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes
F Ugolini et al. Oncogene. 1999.
Abstract
Deletions and amplifications are frequent alterations of the short arm of chromosome 8 associated with various types of cancers, including breast cancers. This indicates the likely presence of tumor suppressor genes and oncogenes. In the present study, we have used the expressed sequence tag (EST) map of 8p11-21 to assemble a set of available cDNAs representing genes from this region. DNA arrays were prepared for expression analysis and search for genes potentially involved in breast cancer. Underexpresion in tumoral breast cells (versus normal breast) was observed for 15 transcripts. Among these, the Frizzled-related gene FRP1/FRZB, was turned off in 78% of breast carcinomas, suggesting that the lack of its product may be associated with malignant transformation. Overexpression in tumoral breast cells was observed for 13 genes. The FGFR1 gene, that encodes a tyrosine kinase receptor for members of the fibroblast growth factor family, was identified as a good candidate for one amplification unit. Taken together, our results demonstrate that such a strategy can rapidly identify genes with an altered pattern of expression and provide candidate genes for malignancies.
Similar articles
- CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Bautista S, Theillet C. Bautista S, et al. Genes Chromosomes Cancer. 1998 Aug;22(4):268-77. Genes Chromosomes Cancer. 1998. PMID: 9669664 - Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers.
Armes JE, Hammet F, de Silva M, Ciciulla J, Ramus SJ, Soo WK, Mahoney A, Yarovaya N, Henderson MA, Gish K, Hutchins AM, Price GR, Venter DJ. Armes JE, et al. Oncogene. 2004 Jul 22;23(33):5697-702. doi: 10.1038/sj.onc.1207740. Oncogene. 2004. PMID: 15184884 - A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
Filippova GN, Lindblom A, Meincke LJ, Klenova EM, Neiman PE, Collins SJ, Doggett NA, Lobanenkov VV. Filippova GN, et al. Genes Chromosomes Cancer. 1998 May;22(1):26-36. Genes Chromosomes Cancer. 1998. PMID: 9591631 - Fibroblast growth factor receptors in breast cancer: expression, downstream effects, and possible drug targets.
Tenhagen M, van Diest PJ, Ivanova IA, van der Wall E, van der Groep P. Tenhagen M, et al. Endocr Relat Cancer. 2012 Jun 18;19(4):R115-29. doi: 10.1530/ERC-12-0060. Print 2012 Aug. Endocr Relat Cancer. 2012. PMID: 22508544 Review. - Fibroblast growth factor receptors in breast cancer.
Wang S, Ding Z. Wang S, et al. Tumour Biol. 2017 May;39(5):1010428317698370. doi: 10.1177/1010428317698370. Tumour Biol. 2017. PMID: 28459213 Review.
Cited by
- Eliminating Cancer Stem Cells by Targeting Embryonic Signaling Pathways.
Oren O, Smith BD. Oren O, et al. Stem Cell Rev Rep. 2017 Feb;13(1):17-23. doi: 10.1007/s12015-016-9691-3. Stem Cell Rev Rep. 2017. PMID: 27730468 Review. - The role of estrogen in the initiation of breast cancer.
Russo J, Russo IH. Russo J, et al. J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):89-96. doi: 10.1016/j.jsbmb.2006.09.004. J Steroid Biochem Mol Biol. 2006. PMID: 17113977 Free PMC article. Review. - Robust selection of cancer survival signatures from high-throughput genomic data using two-fold subsampling.
Lee S, Rahnenführer J, Lang M, De Preter K, Mestdagh P, Koster J, Versteeg R, Stallings RL, Varesio L, Asgharzadeh S, Schulte JH, Fielitz K, Schwermer M, Morik K, Schramm A. Lee S, et al. PLoS One. 2014 Oct 8;9(10):e108818. doi: 10.1371/journal.pone.0108818. eCollection 2014. PLoS One. 2014. PMID: 25295525 Free PMC article. - Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L, Ji X, Liu W, Huang B, Luo W, Liu B, Lei Y, Du S, Vuppalapati A, Luu HH, Haydon RC, He TC, Ren G. Feng Y, et al. Genes Dis. 2018 May 12;5(2):77-106. doi: 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun. Genes Dis. 2018. PMID: 30258937 Free PMC article. Review. - FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.
Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, Powe D, Ellis IO, Reis-Filho JS. Elbauomy Elsheikh S, et al. Breast Cancer Res. 2007;9(2):R23. doi: 10.1186/bcr1665. Breast Cancer Res. 2007. PMID: 17397528 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous